IPIXOTCdelisted

Innovation Pharmaceuticals Inc.

Healthcare·Oncology·Commercial·Wakefield, MA, United States
OncologyRare DiseaseNeurologyImmunologyOphthalmologyCardiovascularInfectious DiseaseMetabolicRespiratoryPainDermatologyNephrologyMusculoskeletalGastroenterologyReproductivePsychiatry

Innovation Pharmaceuticals Inc. (IPIX): 30 pipeline candidates · ~4 mo cash runway · 111 clinical trials. Updated within the last hour.

4.9/10

BioSniper Score

4-factor signal · derived from public data

Cash Runway1.1

3.9 months

Financial Health0.0

D/E 4.74

Pipeline Maturity8.5

Lead: Phase 3

Pipeline Breadth10.0

30 candidates

Catalyst MomentumN/A

N/A

Insider SignalN/A

N/A

A transparent, data-derived signal for Innovation Pharmaceuticals Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$207K

Cash

$864K

Quarterly Burn

$677K

Runway

3.9 mo

Revenue

$0

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~Oct 2026
Today~7 mo out
Catalyst within runway

Pipeline (30 candidates)

Showing 10 of 30 candidates. Sign up for full pipeline.

111 clinical trials·CEO: Mr. Leo Ehrlich CPA

Frequently asked questions

How many drug candidates are in Innovation Pharmaceuticals Inc.'s pipeline?

Innovation Pharmaceuticals Inc. (IPIX) has 30 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is Innovation Pharmaceuticals Inc.'s lead drug candidate?

Innovation Pharmaceuticals Inc.'s most advanced tracked candidate is ac-076 for s.c. administration (Phase 3) for Healthy Subjects.

What is Innovation Pharmaceuticals Inc.'s cash runway?

Based on its most recent reported cash balance and quarterly burn rate, Innovation Pharmaceuticals Inc. has approximately 3.9 months of cash runway.

What is Innovation Pharmaceuticals Inc.'s market capitalization?

Innovation Pharmaceuticals Inc.'s market capitalization is approximately $207K.

Who is the CEO of Innovation Pharmaceuticals Inc.?

Mr. Leo Ehrlich CPA is the chief executive officer of Innovation Pharmaceuticals Inc. (IPIX).

Get the full picture on Innovation Pharmaceuticals Inc.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.